The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel
Abstract
The region consisting of the first and second variable regions (V1V2) of gp120 plays vital roles in the functioning of the HIV-1 envelope (Env). V1V2, which harbors multiple glycans and is highly sequence diverse, is located at the Env apex and stabilizes the trimeric gp120 spike on the virion surface. It shields V3 and the coreceptor binding sites in the prefusion state and exposes them upon CD4 binding. Data from the RV144 human HIV-1 vaccine trial suggested that antibody responses targeting the V1V2 region inversely correlated with the risk of infection; thus, understanding the antigenic structure of V1V2 can contribute to vaccine design. We have determined a crystal structure of a V1V2 scaffold molecule (V1V2ZM109-1FD6) in complex with 830A, a human monoclonal antibody that recognizes a V1V2 epitope overlapping the integrin-binding motif in V2. The structure revealed that V1V2 assumes a five-stranded beta barrel structure with the region of the integrin-binding site (amino acids [aa] 179 to 181) included in a “kink” followed by an extra beta strand. The complete barrel structure naturally presents the glycans on its outer surface and packs into its core conserved hydrophobic residues, including the Ile at position 181 which was highly correlated with vaccinemore »
- Authors:
-
- NYU School of Medicine, NY (United States)
- NYU School of Medicine, NY (United States); Veterans Affairs New York Harbor Healthcare System, New York, NY (United States)
- Publication Date:
- Research Org.:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); National Inst. of Health; National Cancer Inst.; National Inst. of General Medical Sciences
- OSTI Identifier:
- 1213733
- Grant/Contract Number:
- AC02-06CH11357; AI100151; AI082274; AI084119; HL059725; Y1-CO-1020; Y1-GM-1104
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Journal of Virology
- Additional Journal Information:
- Journal Volume: 89; Journal Issue: 15; Journal ID: ISSN 0022-538X
- Publisher:
- American Society for Microbiology
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, and Kong, Xiang-Peng. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. United States: N. p., 2015.
Web. doi:10.1128/JVI.00754-15.
Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, & Kong, Xiang-Peng. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. United States. https://doi.org/10.1128/JVI.00754-15
Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, and Kong, Xiang-Peng. Wed .
"The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel". United States. https://doi.org/10.1128/JVI.00754-15. https://www.osti.gov/servlets/purl/1213733.
@article{osti_1213733,
title = {The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel},
author = {Pan, Ruimin and Gorny, Miroslaw K. and Zolla-Pazner, Susan and Kong, Xiang-Peng},
abstractNote = {The region consisting of the first and second variable regions (V1V2) of gp120 plays vital roles in the functioning of the HIV-1 envelope (Env). V1V2, which harbors multiple glycans and is highly sequence diverse, is located at the Env apex and stabilizes the trimeric gp120 spike on the virion surface. It shields V3 and the coreceptor binding sites in the prefusion state and exposes them upon CD4 binding. Data from the RV144 human HIV-1 vaccine trial suggested that antibody responses targeting the V1V2 region inversely correlated with the risk of infection; thus, understanding the antigenic structure of V1V2 can contribute to vaccine design. We have determined a crystal structure of a V1V2 scaffold molecule (V1V2ZM109-1FD6) in complex with 830A, a human monoclonal antibody that recognizes a V1V2 epitope overlapping the integrin-binding motif in V2. The structure revealed that V1V2 assumes a five-stranded beta barrel structure with the region of the integrin-binding site (amino acids [aa] 179 to 181) included in a “kink” followed by an extra beta strand. The complete barrel structure naturally presents the glycans on its outer surface and packs into its core conserved hydrophobic residues, including the Ile at position 181 which was highly correlated with vaccine efficacy in RV144. The epitope of monoclonal antibody 830A is discontinuous and composed of three segments: (i) Thr175, Tyr177, Leu179, and Asp180at the kink overlapping the integrin-binding site; (ii) Arg153and Val154in V1; and (iii) Ile194at the C terminus of V2. Here, this report thus provides the atomic details of the immunogenic “V2i epitope.”},
doi = {10.1128/JVI.00754-15},
journal = {Journal of Virology},
number = 15,
volume = 89,
place = {United States},
year = {Wed Jul 08 00:00:00 EDT 2015},
month = {Wed Jul 08 00:00:00 EDT 2015}
}
Web of Science
Works referenced in this record:
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
journal, October 2014
- Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr
- Nature, Vol. 514, Issue 7523
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
journal, June 1998
- Wyatt, R.
- Science, Vol. 280, Issue 5371
Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
journal, July 2013
- Mayr, Luzia M.; Cohen, Sandra; Spurrier, Brett
- PLoS ONE, Vol. 8, Issue 7
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
journal, October 2002
- Reeves, P. J.; Callewaert, N.; Contreras, R.
- Proceedings of the National Academy of Sciences, Vol. 99, Issue 21
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
journal, November 2011
- McLellan, Jason S.; Pancera, Marie; Carrico, Chris
- Nature, Vol. 480, Issue 7377
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
journal, February 2014
- Zolla-Pazner, Susan; deCamp, Allan; Gilbert, Peter B.
- PLoS ONE, Vol. 9, Issue 2
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
journal, May 2013
- Pancera, Marie; Shahzad-ul-Hussan, Syed; Doria-Rose, Nicole A.
- Nature Structural & Molecular Biology, Vol. 20, Issue 7
Structural specializations of α 4 β 7 , an integrin that mediates rolling adhesion
journal, January 2012
- Yu, Yamei; Zhu, Jianghai; Mi, Li-Zhi
- The Journal of Cell Biology, Vol. 196, Issue 1
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
journal, November 2014
- Byrareddy, Siddappa N.; Kallam, Brianne; Arthos, James
- Nature Medicine, Vol. 20, Issue 12
Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
journal, August 2014
- Upadhyay, C.; Mayr, L. M.; Zhang, J.
- Journal of Virology, Vol. 88, Issue 21
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
journal, April 2012
- Haynes, Barton F.; Gilbert, Peter B.; McElrath, M. Juliana
- New England Journal of Medicine, Vol. 366, Issue 14
Structure of a V3-Containing HIV-1 gp120 Core
journal, November 2005
- Huang, C. -c.
- Science, Vol. 310, Issue 5750
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998
- Kwong, Peter D.; Wyatt, Richard; Robinson, James
- Nature, Vol. 393, Issue 6686
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
journal, January 2013
- Liao, Hua-Xin; Bonsignori, Mattia; Alam, S. Munir
- Immunity, Vol. 38, Issue 1
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
journal, September 2012
- Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.
- Nature, Vol. 490, Issue 7420
PHENIX : building new software for automated crystallographic structure determination
journal, October 2002
- Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
- Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013
- Julien, J. -P.; Cupo, A.; Sok, D.
- Science, Vol. 342, Issue 6165
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
journal, June 2012
- Gorny, Miroslaw K.; Pan, Ruimin; Williams, Constance
- Virology, Vol. 427, Issue 2
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013
- Lyumkis, D.; Julien, J. -P.; de Val, N.
- Science, Vol. 342, Issue 6165
Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies
journal, May 2011
- van Gils, M. J.; Bunnik, E. M.; Boeser-Nunnink, B. D.
- Journal of Virology, Vol. 85, Issue 14
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
journal, May 2012
- Parrish, Nicholas F.; Wilen, Craig B.; Banks, Lauren B.
- PLoS Pathogens, Vol. 8, Issue 5
XDS
journal, January 2010
- Kabsch, Wolfgang
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold
journal, September 2010
- Totrov, Maxim; Jiang, Xunqing; Kong, Xiang-Peng
- Virology, Vol. 405, Issue 2
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
journal, July 2011
- Zolla-Pazner, S.; Kong, X. - P.; Jiang, X.
- Journal of Virology, Vol. 85, Issue 19
Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
journal, July 2010
- Zolla-Pazner, Susan; Cardozo, Timothy
- Nature Reviews Immunology, Vol. 10, Issue 7
HIV-1 Envelope Subregion Length Variation during Disease Progression
journal, December 2010
- Curlin, Marcel E.; Zioni, Rafael; Hawes, Stephen E.
- PLoS Pathogens, Vol. 6, Issue 12
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
journal, January 1993
- Moore, J. P.; Sattentau, Q. J.; Yoshiyama, H.
- Journal of Virology, Vol. 67, Issue 10
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
journal, January 1987
- Modrow, S.; Hahn, B. H.; Shaw, G. M.
- Journal of Virology, Vol. 61, Issue 2
Coot model-building tools for molecular graphics
journal, November 2004
- Emsley, Paul; Cowtan, Kevin
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009
- Walker, L. M.; Phogat, S. K.; Chan-Hui, P. -Y.
- Science, Vol. 326, Issue 5950
Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIVSF162P4
journal, January 2010
- Robinson, James E.; Franco, Kelly; Elliott, Debra Holton
- Journal of Virology, Vol. 84, Issue 7
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
journal, January 2013
- Zolla-Pazner, Susan; deCamp, Allan C.; Cardozo, Timothy
- PLoS ONE, Vol. 8, Issue 1
Estimated Secondary Structure Propensities within V1/V2 Region of HIV gp120 Are an Important Global Antibody Neutralization Sensitivity Determinant
journal, April 2014
- Totrov, Maxim
- PLoS ONE, Vol. 9, Issue 4
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
journal, February 2008
- Arthos, James; Cicala, Claudia; Martinelli, Elena
- Nature Immunology, Vol. 9, Issue 3
ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation
journal, May 1994
- Abagyan, Ruben; Totrov, Maxim; Kuznetsov, Dmitry
- Journal of Computational Chemistry, Vol. 15, Issue 5
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
journal, January 1994
- Gorny, M. K.; Moore, J. P.; Conley, A. J.
- Journal of Virology, Vol. 68, Issue 12
A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization
journal, July 2013
- Bohl, Christopher; Bowder, Dane; Thompson, Jesse
- PLoS ONE, Vol. 8, Issue 7
Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles
journal, April 2005
- Gorny, Miroslaw K.; Stamatatos, Leonidas; Volsky, Barbara
- Journal of Virology, Vol. 79, Issue 8
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope
journal, August 2014
- Evering, Teresa H.; Kamau, Edwin; St. Bernard, Leslie
- Retrovirology, Vol. 11, Issue 1
Protein modules and signalling networks
journal, February 1995
- Pawson, Tony
- Nature, Vol. 373, Issue 6515
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
journal, January 1987
- Ratner, Lee; Fisher, Amanda; Jagodzinski, Linda L.
- AIDS Research and Human Retroviruses, Vol. 3, Issue 1
Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV
journal, January 2014
- Spurrier, B.; Sampson, J.; Gorny, M. K.
- Journal of Virology, Vol. 88, Issue 8
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
journal, December 2002
- Kwong, Peter D.; Doyle, Michael L.; Casper, David J.
- Nature, Vol. 420, Issue 6916
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
journal, June 1990
- Leonard, C. K.; Spellman, M. W.; Riddle, L.
- Journal of Biological Chemistry, Vol. 265, Issue 18
[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997
- Otwinowski, Zbyszek; Minor, Wladek
- Macromolecular Crystallography Part A, 307-326
Works referencing / citing this record:
Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
journal, January 2018
- Upadhyay, Chitra; Feyznezhad, Roya; Yang, Weiming
- PLOS Pathogens, Vol. 14, Issue 1
The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
journal, October 2017
- Herschhorn, Alon; Gu, Christopher; Moraca, Francesca
- Nature Communications, Vol. 8, Issue 1
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers
journal, April 2018
- Castillo-Menendez, Luis R.; Witt, Kristen; Espy, Nicole
- Journal of Virology, Vol. 92, Issue 12
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
journal, October 2017
- Mayr, Luzia M.; Decoville, Thomas; Schmidt, Sylvie
- Scientific Reports, Vol. 7, Issue 1
Opening dynamics of HIV-1 gp120 upon receptor binding is dictated by a key hydrophobic core
journal, January 2019
- Da, Lin-Tai; Lin, Mengna
- Physical Chemistry Chemical Physics, Vol. 21, Issue 47
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
journal, April 2018
- Wen, Yingxia; Trinh, Hung V.; Linton, Christine E.
- PLOS ONE, Vol. 13, Issue 4
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant
journal, May 2017
- Torres, Oscar B.; Matyas, Gary R.; Rao, Mangala
- npj Vaccines, Vol. 2, Issue 1
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
journal, August 2018
- Lertjuthaporn, Sakaorat; Cicala, Claudia; Van Ryk, Donald
- PLOS Pathogens, Vol. 14, Issue 8
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
journal, October 2018
- Wibmer, Constantinos Kurt; Richardson, Simone I.; Yolitz, Jason
- Nature Communications, Vol. 9, Issue 1
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
journal, January 2018
- Balasubramanian, Preetha; Williams, Constance; Shapiro, Mariya B.
- Scientific Reports, Vol. 8, Issue 1
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response
journal, September 2016
- Zolla-Pazner, Susan; Powell, Rebecca; Yahyaei, Sara
- Journal of Virology, Vol. 90, Issue 24
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
journal, December 2015
- Gorman, Jason; Soto, Cinque; Yang, Max M.
- Nature Structural & Molecular Biology, Vol. 23, Issue 1